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Summary
 Background: Ventilation with high positive end-expiratory pressure (PEEP) can lead to hepatic dysfunction. The 
aim of this study was to investigate the hepatic effects of strategies using high airway pressures ei-
ther in pressure-controlled ventilation (PCV) or in high-frequency oscillatory ventilation (HFOV) 
combined with an arteriovenous extracorporeal lung assist (ECLA).
 Material/Methods: Pietrain pigs underwent induction of lung injury by saline lavage. Ventilation was continued for 24 
hours either as PCV with tidal volumes of 6 ml/kg and PEEP 3 cmH2O above the lower inflection 
point of the pressure-volume curve or as HFOV (≥12 Hz) with a mean tracheal airway pressure 3 
cmH2O above the lower inflection point combined with arteriovenous ECLA (HFOV+ECLA). Fluids 
and norepinephrine stabilized the circulation. The indocyanine green plasma disappearance rate, 
serum bilirubin, aspartate aminotransferase, alanine aminotransferase, g-glutamyltransferase, alka-
line phosphatase, glutamate dehydrogenase, lactate dehydrogenase and creatine kinase were de-
termined repeatedly. Finally, liver neutrophils were counted and liver cell apoptosis was assessed 
by terminal deoxynucleotidyl transferase nick end labeling (TUNEL).
 Results: Aspartate aminotransferase increased in the PCV group about three-fold and in the HFOV+ECLA 
group five-fold (p<0.001). Correspondingly, creatine kinase increased about two-fold and four-fold, 
respectively (p<0.001). Lactate dehydrogenase was increased in the HFOV+ECLA group (p<0.028). 
The number of neutrophils infiltrating the liver tissue and the apoptotic index were low.
 Conclusions: High airway pressure PCV and HFOV with ECLA in the treatment of lavage-induced lung injury 
in pigs did not cause liver dysfunction or damage. The detected elevation of enzymes might be of 
extrahepatic origin.
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Background
Mechanical ventilation is usually necessary to achieve suffi-
cient gas exchange in severe respiratory failure as caused by 
adult respiratory distress syndrome (ARDS) or acute lung 
injury. The aggravation of preexisting lung injury by me-
chanical ventilation was termed ventilator-associated lung 
injury [1]. Ventilator-associated lung injury is caused by al-
veolar overdistension due to high inspiratory pressures and 
tidal volumes, as well as cyclic alveolar closing and reopen-
ing by using insufficient positive end-expiratory pressures 
(PEEP) [2]. Therefore, lung protective ventilation compris-
es increased PEEP and lower tidal volumes, thus recruiting 
atelectatic lung areas and reducing driving and plateau pres-
sures [3]. Lung-protective ventilation can reduce inflamma-
tory mediators [4] and mortality [3] in patients with ARDS.
Nevertheless, limiting tidal volumes to 6 ml/kg body weight 
and plateau pressures to 30 cmH2O might be insufficient in 
certain patients [5]. A further reduction of tidal volumes 
is usually limited by severe respiratory acidosis [6]. High-
frequency oscillatory ventilation (HFOV) produces very 
small tidal volumes at a high mean airway pressure and may 
improve lung protection, but elimination of carbon diox-
ide can also be inadequate, especially with the high oscil-
latory frequencies recommended today [7]. An additional 
pumpless arteriovenous extracorporeal lung assist (ECLA) 
can remove carbon dioxide, while having no relevant effect 
on arterial oxygenation [8]. Hence, strategies enabling a 
greater reduction of tidal volumes in conventional [6,9] or 
HFOV [10,11] in combination with an arteriovenous ECLA 
were developed.
High PEEP ventilation prevented hypoxemia [12] and ac-
celerated weaning from the respirator [13], but did not de-
crease mortality in acute lung injury and ARDS. PEEP may 
lower the cardiac output and increase the backpressure to 
liver venous outflow and liver venous resistance, therefore 
a reduction of liver blood flow [14] and hepatic congestion 
[15] can occur. High levels of PEEP used in critically ill pa-
tients promoted hepatic dysfunction [16]. Hepatic dysfunc-
tion independently increased the length of intensive care 
unit stay and mortality [17]. After experimental lung injury 
in pigs, elevations of hepatic enzymes, bilirubin and neutro-
phil infiltration of liver tissue were detected after 24 hours 
of ventilation with initial recruitment of the lung by high 
levels of PEEP [18]. Until now, no study has examined the 
hepatic effects of airway pressures set consistently above the 
lower inflection point (LIP) of the pressure-volume curve 
throughout 24 hours of ventilation.
In a previous publication by our research group, the com-
bination of HFOV and arteriovenous ECLA showed less his-
topathologic signs of inflammation in the basal lung than 
pressure-controlled low tidal volume ventilation after ex-
perimental lung injury [19]. The PEEP and mean trache-
al airway pressure were set above the LIP and ventilation 
was continued for 24 hours. The aim of the present paper 
was to demonstrate the effects of those two lung-protec-
tive ventilation strategies on liver dysfunction and damage. 
Those data were gathered during the same experiment as 
in the companion paper [19]. Liver dysfunction was mea-
sured by indocyanine green plasma clearance and biliru-
bin serum levels. Liver damage was measured by changes 




This study was conducted according to the German Animal 
Protection Law and was approved by the Laboratory Animal 
Care and Use Committee of the District of Unterfranken, 
Germany (ref. no. 21/06) on 11 July, 2006. To yield eight 
animals per group as in the companion paper [19], a total 
of 18 animals were studied because one animal per group 
was unsuitable for the liver analysis. Juvenile female Pietrain 
pigs negative for malignant hyperthermia were fasted with 
unlimited water access. Premedication, induction of anes-
thesia and neuromuscular blockade were done as described 
before [20]. Intravenous anesthesia was maintained with 
thiopental (5–10 mg∙kg–1∙h–1), fentanyl (10 µg∙kg–1∙h–1) and 
pancuronium bromide (0.1 mg∙kg–1∙h–1). Pressure-controlled 
ventilation (PCV) was performed (Evita XL, Dräger, Lübeck, 
Germany) through a cuffed 7.5 mm inner diameter tracheal 
tube with an additional tip lumen (Rueschelit®, Rüsch AG, 
Kernen, Germany). PEEP was 5 cmH2O and the inspiratory 
airway pressure was adjusted for tidal volumes of 10 ml/kg 
body weight at a rate of 8–12 per minute. Inspiratory ox-
ygen fraction (FiO2) was 1.0 and inspiratory to expiratory 
time ratio was 1:1.
The left carotid artery was cannulated (Vygon, Ecouen, 
France). A central venous catheter and a pulmonary artery 
catheter (131F7, Edwards Lifesciences, Irvine, CA, USA) 
were inserted through the right internal jugular vein. The 
urinary bladder was drained. Lactated isotonic electrolyte 
solution was infused at 4 ml∙kg–1∙h–1 throughout the ex-
periment. Cefazolin (100 mg/kg) was administered every 
8 hours. The core temperature was maintained at 38°C.
Experimental protocol
Baseline measurements were done after 30 minutes of stabili-
zation. Lung injury was induced by lavages with prewarmed 
0.9% sterile saline solution (30 ml/kg), which were repeat-
ed every 10 minutes until the arterial oxygen tension (PaO2) 
was less than 60 mmHg. Additional lavages were done un-
til PaO2 remained stable below 60 mmHg for one hour. 
This model of surfactant depletion has been shown to pro-
duce lung injury stable for at least 24 hours [21]. In order 
to add ventilator-induced lung injury [22], lavages in the 
present experiment were applied during continued venti-
lation with tidal volumes of 10 ml/kg body weight. Then, 
measurements were done (Injury) and the animals were 
randomized into two groups of nine animals each. An in-
spiratory and expiratory pressure-volume curve was gener-
ated by the PV-tool of the respirator to determine the LIP 
[20]. A bolus of 500 ml colloid solution (Voluven 6% HES 
130/0.4, Fresenius Kabi, Bad Homburg, Germany) was in-
fused before sustained inflation of the lungs was performed 
by applying 50 cmH2O for 30 seconds.
In the PCV group, ventilation was continued with PEEP set 3 
cmH2O above the LIP and reduced tidal volumes of 6 ml/kg 
body weight. The respiratory rate was adjusted between 30 
and 40/min to maintain the arterial carbon dioxide tension 
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(PaCO2) below 50 mmHg and pH >7.2. The rate was de-
creased if auto PEEP exceeded 1 cmH2O. In the HFOV+ECLA 
group, 15- and 17-French cannulas were inserted into the 
right femoral artery and left femoral vein, respectively. A 
low-resistance membrane gas exchanger (iLA™, NovaLung®, 
Talheim, Germany) was filled with sterile isotonic saline solu-
tion and was connected to the cannulas after systemic hepa-
rinization with 400 units/kg heparin. The infusion of hepa-
rin was continued with 20 units∙kg–1∙h–1. The same doses of 
heparin were administrated in the PCV group to control for 
known and unknown effects of heparin. Sweep gas flow with 
100% oxygen through the gas exchanger was set between 2 
and 14 l/min to keep the PaCO2 within the target range. 
HFOV was adjusted to achieve a mean tracheal airway pres-
sure (Ptrachea) 3 cmH2O above the LIP, an amplitude of 60 
cmH2O, an oscillatory frequency between 12 and 15 Hz, and 
an inspiratory to expiratory time ratio of 1:1 (Sensor Medics 
3100 B, Yorba Linda, CA, USA). The bias flow was 30 l/min. 
Respiratory and hemodynamic variables were determined af-
ter sustained inflation and starting the designated respirator 
treatment (Recruitment). In both groups, the FiO2 was set be-
tween 0.3 and 1.0 to maintain PaO2 within 90–110 mmHg. 
Respirator settings were adjusted hourly according to arterial 
blood gases. Additional volume administration with colloid 
and crystalloid solution in a 1:1 ratio was adjusted to achieve 
a heart rate below 100/min and a mean arterial pressure 
(MAP) above 60 mmHg. Norepinephrine was given if vol-
ume administration at 8 ml∙kg–1∙h–1 was insufficient to reach 
the target MAP. The animals were killed after 24 hours by an 
overdose of thiopental and embutramid combined with me-
bezoniumiodid (T61, Intervet, Unterschleissheim, Germany).
Measurements
Pressure transducers (xtrans®, pvb® Critical Care GmbH, 
Kirchseeon, Germany) zeroed at the mid-thorax level mea-
sured central venous pressure (CVP) and MAP. A monitor 
(SMU611, Hellige, Freiburg, Germany) showed pressures 
and electrocardiographic heart rate. The Ptrachea was mea-
sured at the tip of the tube (PM8050®, Draeger, Luebeck, 
Germany). Blood gases were analyzed in arterial (SaO2, 
PaO2, PaCO2), mixed venous (SvO2, PvO2) and in blood af-
ter passing the ECLA-membrane (SeO2, PeO2) (ABL 505, 
Radiometer, Copenhagen, Denmark). Cardiac output was 
determined by cardiopulmonary thermodilution [20]. An 
ultrasonic flow probe (HT110 Flowmeter and HXL Sensor, 
Transonic Systems Inc.®, Ithaca, NY, USA) measured the flow 
within the ECLA (ECLAflow). Oxygen concentrations in ar-
terial (caO2), mixed venous (cvO2) and post-ECLA (ceO2) 
blood were: cO2 [ml/l] = (SO2×13.4× hemoglobin con-
centration + PO2×0.031). Body oxygen delivery was: DO2 
[ml/min] = (cardiac output – ECLAflow) × caO2. Body ox-
ygen uptake was: VO2 [ml/min] = cardiac output × (caO2 – 
cvO2) – ECLAflow × (ceO2 – caO2). The indocyanine green 
plasma disappearance rate (ICG-PDR) as a measure for the 
liver excretory function and perfusion was determined non-
invasively after injection of 0.25 mg/kg indocyanine green 
into the right atrium at Baseline, Injury, 6 and 24 hours af-
ter randomization (LiMON and ICG-PULSION®, PULSION 
Medical Systems, Munich, Germany). Arterial blood samples 
were simultaneously drawn for immediate determination of 
serum bilirubin, aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), g-glutamyltransferase (GGT), alka-
line phosphatase, lactate dehydrogenase (LDH), creatine 
kinase, albumin, myoglobin, troponin T, leukocyte count, 
hemoglobin concentration and lactate using routine labo-
ratory methods. Glutamate dehydrogenase (GLDH) was de-
termined at Baseline and 24 hours. The degree of hemolysis 
was determined by absorption spectrometry.
Liver neutrophils and TUNEL
Samples of the left medial liver lobe were fixed in 10% 
formaldehyde and embedded into paraffin. Chloracetate 
esterase staining of granulocytes was done as described pre-
viously [20]. An investigator blinded to the group assign-
ment counted the neutrophil granulocytes within the liver 
sinusoids and extravascular in the midlobar and pericen-
tral region in ten high-power fields (magnification ×630). 
The percentage of terminal deoxynucleotidyl transferase 
nick end labeling (TUNEL)-positive cells to total cells was 
determined as described before [20].
Statistical analysis
Results for continuous data are shown as the mean with stan-
dard deviation. Serial measurements were tested with two-
way repeated measures analysis of variance (ANOVA). For 
significant results, multiple comparisons versus Injury and 
PCV were tested with the Bonferroni t-test. Results of FiO2, 
GLDH, neutrophil counting and TUNEL were not normally 
distributed and are shown as the median with 25th and 75th 
percentiles. Intergroup and intragroup comparisons were 
tested with the Mann-Whitney U test and the Wilcoxon signed 
rank test or Friedman test, respectively. For significant re-
sults, multiple comparisons versus Injury were tested with 
Dunn’s method. SigmaStat for Windows, version 3.5 (Systat 
Software Inc., Point Richmond, USA) was used. P<0.05 was 
considered to indicate a statistically significant difference.
results
One animal of either group was excluded from the analy-
sis: one developed critical hypoxia after lung injury, and an-
other animal showed a liver abscess at autopsy and marked 
leukocytosis. The remaining 16 animals had a mean weight 
of 54±4.3 kg. Fourteen of these animals, 7 per group, were 
also used in the companion paper [19].
Respiratory variables
Lung injury was induced by 5.2±1.6 lavages. Table 1 shows 
respiratory variables. The lavage number, animal weight 
and respiratory variables at Baseline and Injury were not dif-
ferent between both groups. After randomization, a LIP of 
20±1 was determined in the PCV group and 19±3 cmH2O in 
the HFOV+ECLA group. After Recruitment, Ptrachea in the 
HFOV+ECLA group was lower than in the PCV group, but 
comparable with the PEEP in the PCV group (22±3 cmH2O). 
The PaO2 was higher at Recruitment and the FiO2 was lower 
at 6 and 24 hours in the PCV group. Mean PaCO2 increased 
in the PCV group until 24 hours, while PaCO2 remained in 
the normal range in the HFOV+ECLA group.
Hemodynamic variables
Table 2 shows the hemodynamic variables. At Baseline and 
Injury there were no statistically significant differences 
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among groups, except for MAP. The MAP was initially high-
er in the PCV group, but these differences vanished dur-
ing the trial. After Recruitment, heart rate increased in both 
groups. CVP was higher in the PCV group. Cardiac output 
was slightly lower in the PCV group, whereas it was high-
er in the HFOV+ECLA group according to the ECLAflow. 
DO2, VO2 and norepinephrine dose showed no differenc-
es among groups. Total volumes of crystalloid solution 
Baseline Injury Recruitment 6 h 24 h
Ptrachea PCV  11±2*  19±5  29±4*  29±3*  30±4*
(cmH2O) HFOV+ECLA  11±1*  20±3  22±3
#  22±3#  22±3#
FiO2 PCV  1 (1–1)  1 (1–1)  1 (1–1)  0.3 (0.3–0.3)*  0.3 (0.3–0.3)*
HFOV+ECLA  1 (1–1)  1 (1–1)  1 (1–1)  0.4 (0.38–0.59)#  0.35 (0.34–0.51)*,#
PaO2 PCV  565±47*  44±11  327±182*  111±13  107±12
(mmHg) HFOV+ECLA  574±36*  46±20  115±67#  105±25  104±12
PaCO2 PCV  38.6±2.3  40.2±7.1  43.1±3.1  45.7±4.3  49.1±9.8*
(mmHg) HFOV+ECLA  38.5±3.2  39.9±6.3  32.4±7.2*,#  36.9±2.9#  38.9±1.5#
Table 1. Respiratory variables.
Ptrachea, mean tracheal airway pressure; FiO2, inspiratory oxygen fraction; PaO2, arterial oxygen tension; PaCO2, arterial carbon dioxide tension; 
PCV, group ventilated pressure controlled with positive end-expiratory pressure set 3 cmH2O above the lower inflection point; HFOV+ECLA, group 
ventilated with high frequency oscillatory ventilation with Ptrachea set 3 cmH2O above the lower inflection point and extracorporeal lung assist. 
Values are shown at baseline, after lung injury, initial measurements after recruitment, 6 hours and 24 hours after randomization. Values are 
expressed as mean±standard deviation or as median (25–75th percentile). Significant differences (p<0.05): * vs. Injury; # vs. PCV.
Baseline Injury Recruitment 6 h 24 h
Heart rate PCV  70±18  67±18  63±8  86±20*  89±10*
(beats/min) HFOV+ECLA  63±10  66±21  73±18  102±14*  100±11*
MAP PCV  92±8  87±11  91±12  80±4*  74±7*
(mmHg) HFOV+ECLA  79±9#  76±10#  81±11#  79±8  72±8
CVP PCV  7±2  8±3  13±3*  13±2*  16±3*
(mmHg) HFOV+ECLA  6±2  8±2  9±3#  10±2#  12±2*,#
Cardiac output PCV  4.9±1.5  4.6±0.9  3.8±0.6  3±0.6*  3.6±0.8
(l/min) HFOV+ECLA  4.9±1.3  4.3±1.3  5.2±1.1#  4.8±1.1#  4.8±0.8#
ECLAflow PCV
(l/min) HFOV+ECLA  1.5±0.2  1.5±0.2  1.4±0.2
DO2 PCV  657±221*  440±85  500±48  372±58  436±86
(ml/min) HFOV+ECLA  640±177*  435±245  462±177  418±169  421±94
VO2 PCV  166±33  163±17  163±43  151±30  168±29
(ml/min) HFOV+ECLA  157±34  154±62  146±32  141±21  173±70
Norepinephrine PCV  0±0  2±2  3±2  3±3  10±12*
(µg/min) HFOV+ECLA  0±0  4±5  5±5  5±5  13±10*
Table 2. Hemodynamic variables.
MAP, mean arterial pressure; CVP, central venous pressure; ECLAflow, blood flow through extracorporeal lung assist; DO2, body oxygen delivery; VO2, 
body oxygen consumption; PCV, group ventilated pressure controlled with positive end-expiratory pressure set 3 cmH2O above the lower inflection 
point; HFOV+ECLA, group ventilated with high frequency oscillatory ventilation with mean tracheal airway pressure 3 cmH2O above the lower 
inflection point and extracorporeal lung assist. Values are shown at baseline, after lung injury, initial measurements after recruitment, 6 hours and 
24 hours after randomization. Values are expressed as mean±standard deviation. Significant differences (p<0.05): * vs. Injury; # vs. PCV.
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were 10750±886 ml and 10938±563 ml in the PCV and 
HFOV+ECLA groups, respectively. Total volumes of colloid 
solution were 5188±2478 ml and 4813±651 ml, respectively.
Laboratory measurements
Table 3 shows laboratory measurements. At Baseline and 
Injury there were no statistically significant differences 
among groups. After randomization the ICG-PDR slightly 
increased in both groups. AST increased in the PCV group 
about three-fold and in the HFOV+ECLA group about five-
fold. Creatine kinase increased in the PCV group about two-
fold and in the HFOV+ECLA group about four-fold. LDH 
was increased in the HFOV+ECLA group after 24 hours. 
There was a difference among groups for AST, creatine ki-
nase (p<0.001) and LDH (p=0.028). Bilirubin, ALT, GGT, al-
kaline phosphatase and lactate did not increase or dropped 
to lower values, as did albumin.
GLDH did not increase, and there was no statistically sig-
nificant difference between the PCV and the HFOV+ECLA 
group at 24 hours: 0.4 (0.4–0.5) and 0.7 (0.5–1.1) U/l. 
Leukocyte number (data not shown) and hemoglobin con-
centration did not change and were not different between 
both groups. Hemoglobin concentration at Baseline and 24 
hours was 8.6±0.6 g/dl and 9.5±1.4 in the PCV group, while 
it was 8.4±0.5 g/dl and 8.8±2.3 in the HFOV+ECLA group. 
Myoglobin (detection limit 21 µg/l) and Troponin T (de-
tection limit 0.01 µg/l) reaxhed maximum values of 52 µg/l 
and 0.03 µg/l, respectively. The degree of hemolysis at 24 
hours tended to higher values in the HFOV+ECLA group 
(4.9±3.1 vs. 3.4±2.6 arbitrary units; p=0.312).
Liver neutrophils and TUNEL
Table 4 shows the results of neutrophil counting. Neutrophil 
numbers in the sinusoids of the midlobar liver regions were 
not different between both groups. The number of extravas-
cular neutrophils was low in both groups. In the sinusoids 
of the pericentral regions there was a slight trend to high-
er neutrophil numbers in the HFOV+ECLA group. This 
trend was more prominent for extravascular neutrophils, 
but their numbers were low. The median index of apoptot-
ic cells as determined by TUNEL labeling was low and not 
Baseline Injury 6 h 24 h
ICG-PDR PCV  11.2±2.4  12.3±2.7  13.2±3.4  15.1±2.1*
(%/min) HFOV+ECLA  10.8±2.4  12.7±3.4  12.8±3.1  16.1±3.3*
Bilirubin PCV  3.8±1.5  2.4±0.9  2.8±0.9  3.2±0.6
(µmol/l) HFOV+ECLA  3.4±2  2.8±1.6  4.1±1.3  3.8±1.2
AST PCV  27.1±5.1  35.1±5.9  52.6±19.1  103.6±47*
(U/l) HFOV+ECLA  27.6±9.5  32.8±7.5  50.7±12  178.7±66.5*,#
ALT PCV  40.9±14.1  40.3±13.3  34.5±14.3*  24.8±10*
(U/l) HFOV+ECLA  42.4±15.2  38.8±15.5  28.4±11.7*  24.6±8.5*
GGT PCV  37.9±8.2  37.9±5.8  36.6±13.3  25.3±7.9*
(U/l) HFOV+ECLA  32.7±5.5  38.6±4.7  30.5±3.7  24.5±4.8*
Alkaline PCV  77±23  79±18  77±22  68±18
phosphatase (U/l) HFOV+ECLA  65±9  67±14  61±9  63±16
LDH PCV  541±128  487±197  516±135  496±138
(U/l) HFOV+ECLA  490±69  484±67  450±79  648±181*,#
Creatine kinase PCV  570±185  965±350  984±313  2067±474*
(U/l) HFOV+ECLA  509±107  725±196  995±461  2988±1090*,#
Albumin PCV  25±3  25±3  21±3*  15±3*
(g/l) HFOV+ECLA  25±2  23±3  17±3*,#  14±4*
Lactate PCV  3±1.7*  1.6±0.4  1.8±0.7  2±1.1
(mmol/l) HFOV+ECLA  2.8±2.1  2.1±0.7  2.5±0.6  2.1±0.7
Table 3. Laboratory measurements.
ICG-PDR, indocyanine green plasma disappearance rate; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, 
γ-glutamyltransferase; LDH, lactate dehydrogenase; PCV, group ventilated pressure controlled with positive end-expiratory pressure set 3 cmH2O 
above the lower inflection point; HFOV+ECLA, group ventilated with high frequency oscillatory ventilation with mean tracheal airway pressure 3 
cmH2O above the lower inflection point and extracorporeal lung assist. Values are shown at baseline, after lung injury, 6 hours and 24 hours after 
randomization. Values are expressed as mean±standard deviation. Significant differences (p<0.05): * vs. Injury; # vs. PCV.
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different between the PCV and the HFOV+ECLA group: 
0.08% (0–0.21) and 0.14% (0.13–0.24).
discussion
We examined the hepatic consequences of high airway 
pressure ventilation with PCV using protective low tidal vol-
umes and HFOV combined with ECLA. No obvious liver 
dysfunction or damage was found; however, AST and cre-
atine kinase increased. In the HFOV+ECLA group these 
changes were more prominent and LDH was also elevated. 
Neutrophil accumulation in the liver sinusoids was shown 
in both groups, as well as a small number of neutrophils in-
filtrating the liver parenchyma.
There are several possible explanations for the enzyme ele-
vations. Since no significant levels of Troponin T and myo-
globin were found, creatine kinase probably did not origi-
nate from muscle tissue. Creatine kinase serum levels were 
elevated after ischemic liver injury in rats [23]. This cre-
atine kinase was the BB isoform, which was found in liver 
endothelial and Kupffer cells. Imai et al found that injuri-
ous ventilation with high tidal volumes elicited the eleva-
tion of AST and LDH and more apoptosis in the kidney 
and small intestine, but not in the liver [24]. One-lung ven-
tilation caused elevations of serum AST, ALT and liver my-
eloperoxidase activity, liver cell apoptosis and microscopic 
signs of hepatic damage [25]. Injurious mechanical venti-
lation in mice increased the expression of adhesion mole-
cules associated with recruitment of granulocytes into the 
liver and kidney [26]. Therefore, ventilation or the lung 
injury might have elicited hepatic changes in the present 
study. But since more specific enzymes, as ALT and GLDH, 
and also bilirubin were not elevated, the pattern of labora-
tory results did not confirm liver damage. Serum ALT and 
GGT were reduced, most probably as a consequence of he-
modilution due to the fluid volumes infused, since albumin 
decreased similarly. Nevertheless, the hemoglobin concen-
tration did not change. Neutrophil accumulation in the liv-
er does not implicate liver damage. Neutrophils can adhere 
to the sinusoids for rheological reasons, but only cells that 
emigrate into the parenchyma can damage the tissue [27]. 
In fact, the number of extravascular neutrophils was very 
low compared to the number of neutrophils found within 
the sinusoids. Moreover, hepatocyte apoptosis as detected 
by TUNEL was sparse. In summary, clinically relevant liver 
damage cannot be concluded from the results.
The membrane gas exchanger might have caused some he-
molysis. Absorption spectrometry showed a trend toward 
more hemolysis in the HFOV+ECLA group. LDH, AST and 
less prominently, creatine kinase, are elevated in hemolyt-
ic blood samples [28]. Therefore, hemolysis might explain 
the group differences in these enzymes, but not the eleva-
tion of AST and creatine kinase in both groups.
Other studies have also tested liver changes in pigs during 
ventilation after lavage-induced lung injury. Dembinski and 
colleagues published a similar 24-hour trial that, however, 
used relatively low airway pressures [9]. They compared ven-
tilation with tidal volumes of 6 ml/kg and ventilation with 
3 ml/kg in combination with ECLA. They reported no dif-
ferences in bilirubin, AST, ALT, alkaline phosphatase, cre-
atine kinase and histologic liver injury between the groups. 
However, it was not reported whether these measurements 
changed during the trial in both groups. In our previous 
investigation, prolonged recruitment with an incremental 
and decremental PEEP trial was associated with elevations 
of AST, LDH and bilirubin as soon as after 6 hours [18]. 
These findings were more prominent after 24 hours, but 
minor elevations of AST and LDH were also present in a 
group with 5 cmH2O of PEEP without recruitment. The peak 
PEEP levels were higher than in the present study and ad-
ditional fluids were only given in critical hypotension. This 
might have yielded the more striking changes in laboratory 
results. In a recent study comparing an open lung strategy 
with high PEEP and a strategy with low PEEP, we found el-
evations of AST until the end of the trial after 6 hours, but 
no increase of LDH or bilirubin [20]. Both studies [18,20] 
showed a more prominent granulocyte infiltration of the 
liver with higher PEEP. The present study extends the find-
ings of our recent publication [20], because the duration 
of ventilation was longer, the strategy of circulatory stabili-
zation was different, and HFOV combined with an arterio-
venous ECLA was investigated.
In our present study, the Ptrachea in the HFOV+ECLA 
group was comparable to the PEEP in the PCV group. 
Thus, the mean airway pressure and CVP were lower in 
the HFOV+ECLA group. The liver blood flow during con-
ventional positive pressure ventilation and high-frequency 
ventilation was shown to depend on the mean airway pres-
sure, not on the mode of ventilation [29]. Cardiac output, 
DO2 and VO2 were comparable between both groups if 
ECLAflow was considered. Consequently, we assume that 
the hepatic blood flow was similar or less impaired in the 
HFOV+ECLA group. During expiration, the effective air-
way pressures were presumably comparable in the PCV and 
the HFOV+ECLA group. Negligible pressure swings were 
probably transmitted outside the respiratory system due to 
the high oscillation frequencies in the HFOV+ECLA group. 
Therefore, less or at least similar liver venous congestion 
was expected in this group. Thus, hemodynamic differences 
could not explain the differences in enzyme measurements. 
PCV HFOV+ECLA P-value
Midlobar region
Sinusoidal  9.4 (6.6–12.2)  8.1 (5.1–11.7) 0.80
Extravascular  0.6 (0.2–1.0)  0.6 (0.3–0.8) 0.65
Pericentral region
Sinusoidal  10.9 (4.9–17.5)  17.1 (6.7–40.8) 0.28
Extravascular  1.1 (0.4–3.9)  4.6 (2.9–8.0) 0.08
Table 4. Liver neutrophils.
PCV, group ventilated pressure controlled with positive end-expiratory 
pressure set 3 cmH2O above the lower inflection point; HFOV+ECLA, 
group ventilated with high frequency oscillatory ventilation with 
mean tracheal airway pressure set 3 cmH2O above the lower inflection 
point and extracorporeal lung assist. Average numbers of neutrophil 
granulocytes in ten high power fields (magnification ×630) found 
within the liver sinusoids and extravascular in the midlobar and 
pericentral region were used. Values are expressed as median (25–75th 
percentile). P-values: Results of intergroup comparisons.
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The hemodynamic support with volume administration in 
combination with norepinephrine administration provided 
a better stabilization of cardiac output than in a group with 
volume restriction in our recent study [20]. In that study, 
we used a similar high PEEP ventilation strategy as in our 
PCV group. However, splanchnic oxygen uptake was not re-
duced in this study because of the high oxygen extraction 
[20]. Therefore, we presume that liver perfusion and ox-
ygen supply was sufficient in the present experiment. The 
enzyme elevations could be caused by hepatic congestion 
or had a different source.
This study had certain limitations. It was performed in 
young pigs and not in human patients, and the lung injury 
was not necessarily comparable to human ARDS. Because 
we included no animals without lung injury, we cannot ex-
clude that the induction of the lung injury or even the lung 
injury itself was in part responsible for the changes found 
in our study. Sampling hepatovenous blood would have al-
lowed determining whether the elevated enzymes originat-
ed from the liver. The effects of the HFOV cannot be sep-
arated from the effects of the ECLA. Therefore, including 
an ECLA to the PCV group would enhance comparability 
between both strategies.
conclusions
Lung protective ventilation above the lower inflection point 
of the pressure-volume curve with PCV or HFOV+ECLA for 
24 hours in pigs with lavage-induced lung injury did not 
cause obvious liver dysfunction or damage. A prerequisite 
might be the applied strategy of fluid administration and 
catecholamine therapy resulting in a nearly sustained cardi-
ac output. The detected elevation of AST, LDH and creatine 
kinase might be of extrahepatic origin. This study cannot 
exclude the possibility that hepatic effects may be present 
in animals or humans receiving insufficient circulatory sta-
bilization or suffering from preexisting impairment of liv-
er function or perfusion.
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